CVRx (CVRX) Cash from Investing Activities (2020 - 2026)
CVRx (CVRX) posted Cash from Investing Activities of -$112000.0 for Q2 2026, up 8.2% on a QoQ basis from -$122000.0 in Q1 2026, and down 8.74% year-over-year from -$122723.4 in Q2 2025.
Analysis
CVRx (CVRX) Cash from Investing Activities (2020 - 2026) Analysis & Trends
CVRx has reported Cash from Investing Activities for 7 years, with the latest figure at -$112000.0 in Q2 2026.
- On a quarterly basis, Cash from Investing Activities fell 8.74% year-over-year to -$112000.0 in Q2 2026; TTM through Jun 2026 was -$597000.0, a 95.1% decrease from a year earlier, with the FY2025 full-year figure at -$580000.0, up 57.38% from the prior year.
- Cash from Investing Activities was -$112000.0 for Q2 2026 at CVRx, up from -$122000.0 in the prior quarter.
- The five-year high for Cash from Investing Activities was -$37000.0 in Q3 2024, with the low at -$917000.0 in Q1 2024.
- Average Cash from Investing Activities over 5 years is -$191722.2, with a median of -$118000.0 recorded in 2025.
- The largest YoY upside for Cash from Investing Activities was 87.57% in 2025 against a maximum downside of 697.3% in 2025.
- Over 5 years, Cash from Investing Activities stood at -$79000.0 in 2022, then plunged by 113.92% to -$169000.0 in 2023, then soared by 69.23% to -$52000.0 in 2024, then tumbled by 30.77% to -$68000.0 in 2025, then plunged by 64.71% to -$112000.0 in 2026.
- The last three Cash from Investing Activities figures came in at -$112000.0 (Q2 2026), -$122000.0 (Q1 2026), and -$68000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | -26.60 Mn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | -1.62 Bn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | -639.00 Mn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | -1.96 Bn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | -193.20 Mn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | -222.00 Mn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | 329.80 Mn |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | -108.50 Mn |
| 10 | CVRx | 81.26 Mn | 16.67 Mn | 13.72 Mn | -112,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -112,000.00 |
| Mar 31, 2026 | -122,000.00 |
| Dec 31, 2025 | -68,000.00 |
| Sep 30, 2025 | -295,000.00 |
| Jun 30, 2025 | -103,000.00 |
| Mar 31, 2025 | -114,000.00 |
| Dec 31, 2024 | -52,000.00 |
| Sep 30, 2024 | -37,000.00 |
| Jun 30, 2024 | -355,000.00 |
| Mar 31, 2024 | -917,000.00 |
| Dec 31, 2023 | -169,000.00 |
| Sep 30, 2023 | -39,000.00 |
| Jun 30, 2023 | -143,000.00 |
| Mar 31, 2023 | -240,000.00 |
| Dec 31, 2022 | -79,000.00 |
| Sep 30, 2022 | -264,000.00 |
| Jun 30, 2022 | -49,000.00 |
| Mar 31, 2022 | -293,000.00 |
| Dec 31, 2021 | -538,000.00 |
| Sep 30, 2021 | -165,000.00 |